238 related articles for article (PubMed ID: 28741478)
1. Targeting the Microenvironment in Advanced Colorectal Cancer.
Tauriello DVF; Batlle E
Trends Cancer; 2016 Sep; 2(9):495-504. PubMed ID: 28741478
[TBL] [Abstract][Full Text] [Related]
2. Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment.
Itatani Y; Kawada K; Sakai Y
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31756952
[TBL] [Abstract][Full Text] [Related]
3. Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis.
Jackstadt R; van Hooff SR; Leach JD; Cortes-Lavaud X; Lohuis JO; Ridgway RA; Wouters VM; Roper J; Kendall TJ; Roxburgh CS; Horgan PG; Nixon C; Nourse C; Gunzer M; Clark W; Hedley A; Yilmaz OH; Rashid M; Bailey P; Biankin AV; Campbell AD; Adams DJ; Barry ST; Steele CW; Medema JP; Sansom OJ
Cancer Cell; 2019 Sep; 36(3):319-336.e7. PubMed ID: 31526760
[TBL] [Abstract][Full Text] [Related]
4. Role of TGF-β in metastatic colon cancer: it is finally time for targeted therapy.
Villalba M; Evans SR; Vidal-Vanaclocha F; Calvo A
Cell Tissue Res; 2017 Oct; 370(1):29-39. PubMed ID: 28560691
[TBL] [Abstract][Full Text] [Related]
5. Targeting the tumor microenvironment as a potential therapeutic approach in colorectal cancer: Rational and progress.
Bahrami A; Khazaei M; Hassanian SM; ShahidSales S; Joudi-Mashhad M; Maftouh M; Jazayeri MH; Parizade MR; Ferns GA; Avan A
J Cell Physiol; 2018 Apr; 233(4):2928-2936. PubMed ID: 28574572
[TBL] [Abstract][Full Text] [Related]
6. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
7. The Role of TGF-β Signaling Regulatory MicroRNAs in the Pathogenesis of Colorectal Cancer.
Moradi-Marjaneh R; Khazaei M; Ferns GA; Aghaee-Bakhtiari SH
Curr Pharm Des; 2018; 24(39):4611-4618. PubMed ID: 30636580
[TBL] [Abstract][Full Text] [Related]
8. Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation.
Calon A; Espinet E; Palomo-Ponce S; Tauriello DV; Iglesias M; Céspedes MV; Sevillano M; Nadal C; Jung P; Zhang XH; Byrom D; Riera A; Rossell D; Mangues R; Massagué J; Sancho E; Batlle E
Cancer Cell; 2012 Nov; 22(5):571-84. PubMed ID: 23153532
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of colorectal liver metastasis development.
Shasha T; Gruijs M; van Egmond M
Cell Mol Life Sci; 2022 Nov; 79(12):607. PubMed ID: 36436127
[TBL] [Abstract][Full Text] [Related]
10. The Role of Tumor-Associated Neutrophils in Colorectal Cancer.
Mizuno R; Kawada K; Itatani Y; Ogawa R; Kiyasu Y; Sakai Y
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30691207
[TBL] [Abstract][Full Text] [Related]
11. Focal adhesion molecule Kindlin-1 mediates activation of TGF-β signaling by interacting with TGF-βRI, SARA and Smad3 in colorectal cancer cells.
Kong J; Du J; Wang Y; Yang M; Gao J; Wei X; Fang W; Zhan J; Zhang H
Oncotarget; 2016 Nov; 7(46):76224-76237. PubMed ID: 27776350
[TBL] [Abstract][Full Text] [Related]
12. GFI1 downregulation promotes inflammation-linked metastasis of colorectal cancer.
Xing W; Xiao Y; Lu X; Zhu H; He X; Huang W; Lopez ES; Wong J; Ju H; Tian L; Zhang F; Xu H; Wang SD; Li X; Karin M; Ren H
Cell Death Differ; 2017 May; 24(5):929-943. PubMed ID: 28387757
[TBL] [Abstract][Full Text] [Related]
13. TGFβ and the Tumor Microenvironment in Colorectal Cancer.
Waldner MJ; Neurath MF
Cells; 2023 Apr; 12(8):. PubMed ID: 37190048
[TBL] [Abstract][Full Text] [Related]
14. miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition.
Zhao S; Sun H; Jiang W; Mi Y; Zhang D; Wen Y; Cheng D; Tang H; Wu S; Yu Y; Liu X; Cui W; Zhang M; Sun X; Zhou Z; Peng Z; Yan D
Mol Cancer; 2017 Jan; 16(1):12. PubMed ID: 28095858
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer characterization and therapeutic target prediction based on microRNA expression profile.
Xu P; Zhu Y; Sun B; Xiao Z
Sci Rep; 2016 Feb; 6():20616. PubMed ID: 26852921
[TBL] [Abstract][Full Text] [Related]
16. miR-1269 promotes metastasis and forms a positive feedback loop with TGF-β.
Bu P; Wang L; Chen KY; Rakhilin N; Sun J; Closa A; Tung KL; King S; Kristine Varanko A; Xu Y; Huan Chen J; Zessin AS; Shealy J; Cummings B; Hsu D; Lipkin SM; Moreno V; Gümüş ZH; Shen X
Nat Commun; 2015 Apr; 6():6879. PubMed ID: 25872451
[TBL] [Abstract][Full Text] [Related]
17. alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression.
Swallow CJ; Partridge EA; Macmillan JC; Tajirian T; DiGuglielmo GM; Hay K; Szweras M; Jahnen-Dechent W; Wrana JL; Redston M; Gallinger S; Dennis JW
Cancer Res; 2004 Sep; 64(18):6402-9. PubMed ID: 15374947
[TBL] [Abstract][Full Text] [Related]
18. NR2F2 inhibits Smad7 expression and promotes TGF-β-dependent epithelial-mesenchymal transition of CRC via transactivation of miR-21.
Wang H; Nie L; Wu L; Liu Q; Guo X
Biochem Biophys Res Commun; 2017 Mar; 485(1):181-188. PubMed ID: 28192117
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
20. Determinants of metastatic competency in colorectal cancer.
Tauriello DV; Calon A; Lonardo E; Batlle E
Mol Oncol; 2017 Jan; 11(1):97-119. PubMed ID: 28085225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
